IP Library Granted Patent US 6,905,862
Granted Patent B2
US 6,905,862 · App. 10/267,865 · Granted Jun 14, 2005

Method for producing recombinant adenovirus

Assignee: Centelion
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,905,862
App. No.
10/267,865
Granted
Jun 14, 2005
Kind
B2
Abstract

The invention concerns a method for producing recombinant adenovirus by which viral DNA is introduced in a packaging cell culture and the viruses produced are harvested after liberation in the supernatant. The invention also concerns the viruses produced and their use.

Claims (14)

1. A single chromatography step method for purifying adenovirus from a biological medium, the method comprising:

obtaining a biological medium comprising adenovirus;

performing a single chromatography step comprising anion-exchange chromatography on the biological medium; and

recovering the adenovirus with an adenoviral particle yield of at least 70% of the viral particles present in the biological medium prior to chromatography.

2. The method according to claim 1 , wherein the adenovirus is recombinant.

3. The method according to claim 2 , wherein the biological medium is a supernatant of encapsidation cells producing the adenovirus.

4. The method according to claim 2 , wherein the biological medium is a lysate of encapsidation cells producing the adenovirus.

5. The method according to claim 2 , wherein the biological medium is a prepurified solution of the adenovirus.

6. The method according to claim 2 , wherein the anion-exchange chromatography is on a support functionalized with a quaternary amine.

7. The method according to claim 6 , wherein the support is agarose, dextran, acrylamide, silica, poly(styrene-divinylbenzene), or ethylene glycol-methacrylate copolymer, or a mixture thereof.

8. The method of claim 6 , wherein the anion-exchange chromatography is performed on a Source Q, Mono Q, Q Sepharose, Poros HQ, Poros QE, Fractogel TMAE or Toyopearly Super Q.

9. The method of claim 8 , wherein the Source Q is Source 15Q.

10. The method according to claim 2 , further comprising performing ultrafiltration on the biological medium, or the anion-exchange chromatography fraction, or both.

11. The method of claim 10 , wherein the ultrafiltration is tangential ultrafiltration on a membrane having a cut-off ranging from 300 to 500 kDa.

Assignments (2)
CHANGE OF NAME Recorded Nov 22, 2004
From: GENCELL S.A.
To: GENCELL S.A.S.
Reel/Frame 015402/0459 →
CHANGE OF NAME Recorded Nov 22, 2004
From: GENCELL S.A.S.
To: CENTELION
Reel/Frame 015402/0476 →
Priority Claims (1)
FR 96 08164 · Jul 1, 1996 · national
Continuity (3)
Division 0920254500
Provisional Application 6002666700 · Sep 25, 1996
Related Publication 20030143730A1 · Jul 31, 2003